29 Hyperandrogenic syndrome (HAS) is associated with insulin resistance (IR) and type 2 diabetes. Muscle 30 IR in type 2 diabetes is linked with defects in mitochondrial oxidative capacity. In-vivo muscle 31 mitochondrial function has not been studied in HAS, especially in youth, who are early in the disease 32 
therapeutic intervention. 48
49

INTRODUCTION:
50 Hyperandrogenic syndrome (HAS), also known as polycystic ovarian syndrome (PCOS), 51 affects at least 10-15% of the female population in the United States, with a recent increase in 52 prevalence associated with rising obesity rates (32). Women with HAS have a 3-4 fold increased 53 risk of developing type 2 diabetes (T2D) compared to BMI-matched controls (37, 58) . This 54 increased risk is thought to be secondary to long standing insulin resistance (IR) (37). There is 55 also evidence of IR in youth with HAS (2). Similar to findings in T2D, peripheral IR as assessed 56 with a hyperinsulinemic euglycemic clamp has been well documented in adults with HAS (7, 57 15), with similar but fewer data in youth (2). However, the mechanism of IR in HAS remains 58 uncertain, and as a result the best treatments for HAS are also unclear.
59
A leading theory explaining IR in T2D includes defects in mitochondrial function in 60 combination with excess serum free fatty acids which can cause alterations in intracellular 61 insulin signaling (52). Other potential mechanisms involve altered fat metabolism and 62 inflammation, which have been documented in T2D and HAS, but have not been examined in 63 adolescents with HAS (14, 25, 29, 33, 54) . However, data examining the role of mitochondria in investigators found abnormalities in myotubes from T2D participants (19, 36 Results from the regression models are shown in which can interfere with downstream insulin signaling by excess serine phosphorylation(52).
252
The specific change of increased serine phosphorylation of the insulin receptor has been 253 documented in muscle from women with HAS (17), and it is possible that this mechanism is also 254 occurring in our youth with HAS.
255
We found significant peripheral IR in obese girls with HAS, similar to other studies, with (4, 5, 24, 29, 33) . In obese teens with IR, mitochondrial dysfunction begins in mid-puberty 287 (Tanner 3), and IR is associated with elevated androgens (20, 34, 35 Because the outcome (GIR) was log-transformed, parameter estimates have the following interpretation: the outcome changes by 100*(parameter estimate)% for a one unit increase in the covariate, while all other covariates are held constant.
